UnitedHealth Group Incorporated $UNH Position Increased by Arnhold LLC

Key Points

• Arnhold LLC increased its stake in UnitedHealth Group by 7.9%, now holding 48,063 shares valued at $25.17 million, making it the 7th largest holding in their portfolio.
• UnitedHealth Group reported earnings per share of $4.08 for the last quarter, missing estimates by $0.37, while its quarterly revenue reached $111.62 billion.
• The company declared a quarterly dividend of $2.21 per share, which equates to an annualized dividend yield of 2.9%.

Arnhold LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 7.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 48,063 shares of the healthcare conglomerate's stock after buying an additional 3,512 shares during the period. UnitedHealth Group comprises 2.5% of Arnhold LLC's investment portfolio, making the stock its 7th largest holding. Arnhold LLC's holdings in UnitedHealth Group were worth $25,173,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the business. Monetary Management Group Inc. increased its stake in UnitedHealth Group by 1.0% during the 1st quarter. Monetary Management Group Inc. now owns 7,847 shares of the healthcare conglomerate's stock worth $4,110,000 after buying an additional 75 shares during the period. Norinchukin Bank The increased its stake in UnitedHealth Group by 13.5% during the 1st quarter. Norinchukin Bank The now owns 59,444 shares of the healthcare conglomerate's stock worth $31,134,000 after buying an additional 7,069 shares during the period. CW Advisors LLC increased its stake in UnitedHealth Group by 44.3% during the 1st quarter. CW Advisors LLC now owns 31,136 shares of the healthcare conglomerate's stock worth $16,275,000 after buying an additional 9,564 shares during the period. Summit Financial LLC increased its position in shares of UnitedHealth Group by 2.1% in the 1st quarter. Summit Financial LLC now owns 25,249 shares of the healthcare conglomerate's stock valued at $13,224,000 after purchasing an additional 520 shares during the last quarter. Finally, Kaufman Rossin Wealth LLC purchased a new stake in shares of UnitedHealth Group in the 1st quarter valued at approximately $438,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have commented on UNH. HSBC reissued a "reduce" rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Robert W. Baird reissued an "underperform" rating and issued a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. TD Cowen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. Finally, Royal Bank Of Canada dropped their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $365.38.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $3.7480 during midday trading on Friday, hitting $307.0980. 14,867,565 shares of the company's stock were exchanged, compared to its average volume of 23,516,492. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $278.13 billion, a price-to-earnings ratio of 13.31, a price-to-earnings-growth ratio of 1.98 and a beta of 0.43. The firm's 50 day simple moving average is $288.39 and its 200 day simple moving average is $388.53.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the business posted $6.80 earnings per share. The company's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.